Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ViaNase + corticosteroid is a drug-device combination product being developed by Kurve Therapeutics for the treatment of chronic sinusitis. The product utilizes Kurve's proprietary ViaNase device, which employs Controlled Particle Dispersion (CPD) technology to deliver a reformulated corticosteroid intranasally. The ViaNase device is designed to deliver medication precisely to the nasal mucosa and paranasal sinuses, providing more predictable and controlled intranasal drug delivery compared to traditional nasal spray bottles. While the ViaNase platform is often associated with nose-to-brain delivery for neurological conditions, in this application, it is used to reduce sinonasal inflammation in patients with chronic sinusitis by ensuring the steroid reaches the affected tissues effectively.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ViaNase + corticosteroid.